Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Green Flags for Vertex Pharmaceuticals' Future


Biotech Vertex Pharmaceuticals (NASDAQ: VRTX) is defying the stock market sell-off this year. The drugmaker's shares are up by an impressive 22% year to date. While that's great news for shareholders, it's essential to look beyond a mere six months' worth of stock market performances.

Those in it for the long haul will want to know whether Vertex is likely to keep up this pace. Fortunately, there are good reasons to think the biotech has what it takes to continue beating the market. Let's look at two of these reasons.

VRTX Chart

Continue reading


Source Fool.com

Like: 0
Share

Comments